425: Strive, Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. are moving forward with a proposed business combination, as detailed in a recent communication by Strive's CEO.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication regarding this transaction was reposted by Matthew Cole, Chief Executive Officer of Strive, Inc., on X.com on September 29, 2025.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Information regarding participants in the solicitation of proxies, including directors and executive officers of both companies, will be detailed in the Information Statement/Proxy Statement/Prospectus.

Sentiment

Score: 6

Explanation: The filing announces a proposed business combination with potential strategic and financial benefits, but also highlights numerous significant risks and uncertainties inherent in such transactions, including integration challenges and dilution.

Positives

• The proposed business combination is expected to yield strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are a key objective of the transaction.

Negatives

• The proposed transaction may not close as expected or at all if conditions are not met.
• Integration of the two companies could be more difficult, time-consuming, or costly than anticipated.
• The transaction may be more expensive or take longer to complete due to unexpected factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of Class A common stock in connection with the transaction will cause dilution for existing shareholders.
• There is a potential for adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price may occur before the closing of the transaction.

Risks

• The merger agreement could be terminated due to various events, changes, or circumstances.
• Conditions to closing the proposed transaction may not be received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings instituted against Strive, Semler Scientific, or the combined company could be adverse.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks associated with Bitcoin and other digital assets, and changes in implementation of Bitcoin treasury strategies, could impact anticipated benefits.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could affect the transaction's success.
• Integration of the two companies may prove more difficult, time-consuming, or costly than projected.
• The proposed transaction could be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities is a concern.
• Dilution of Strive's Class A common stock will occur due to the issuance of additional shares for the transaction.
• Potential adverse reactions from customers or changes to business or employee relationships may arise from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could impact the transaction.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

Management expresses expectations regarding the proposed transaction, including anticipated strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the combined businesses. They anticipate cost savings and strategic gains from the merger.

Management Comments

• Matthew Cole, CEO of Strive, Inc., reposted the communication on X.com in connection with the proposed business combination with Semler Scientific, Inc.

Industry Context

The mention of Bitcoin treasury strategies and associated digital asset risks suggests a unique strategic direction for Semler Scientific, a healthcare company, potentially indicating a broader trend of companies diversifying treasury holdings into digital assets, which could differentiate it from traditional industry peers.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of new Class A common stock.
• Shareholders of Semler Scientific will need to make a voting decision on the proposed transaction.
• Customers of both companies may have adverse reactions to the merger.
• Employee relationships at both companies could be affected by the business combination.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Key Dates

Recommendation

The proposed business combination presents both potential strategic benefits and substantial risks, including integration challenges, dilution, and market uncertainties. Investors should hold their positions pending further details on the merger terms, financial projections for the combined entity, and the successful navigation of regulatory and shareholder approvals.

Keywords

Strive Inc, Semler Scientific, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Bitcoin Treasury Strategy, Digital Assets, Corporate Governance